Litigation Details for IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-04-13 |
Court | District Court, D. Delaware | Date Terminated | 2019-09-10 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 10,092,008; 7,691,411; 7,723,390 | ||
Attorneys | Brian P. Egan | ||
Firms | Shaw Keller LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc.
Biologic Drugs cited in IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc.
Details for IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-08-20 | 107 | Opinion - Memorandum Opinion | of multiple terms in U.S. Patent No. 7,723 ,390 ('" 390 Patent"). (D.I. 70). I have considered… construction for multiple terms in U.S. Patent No. 7,723,390. Within five days the parties shall submit…quot; It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification…compositions for thyroid hormones. ('390 Patent at 1:6-7). The patent descends from an Italian priority application | External link to document |
2019-09-10 | 111 | Order | claims of U.S. Patent No. 7,723,390 (" the ' 390 patent") set forth below are…appears in independent claim 1 of the ' 390 patent, and claims 2, 4, 7, 8, and 9 each depend from … claims 1, 2, 4, 7, 8, and 9 of the ' 390 patent are invalid under 35 U.S.C. § 112; and …asserted claims 1, 2, 4, and 7-9 of the ' 390 patent are invalid under 35 U.S.C. § 112; and it is further… 10 September 2019 1:18-cv-00555 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2019-09-12 | 113 | Order and Final Judgment | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,691,411 B2; 7,723,390 B2. (… 10 September 2019 1:18-cv-00555 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2018-04-13 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,691,411 B2; 7,723,390 B2. (… 10 September 2019 1:18-cv-00555 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |